X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22) 22
oncology (22) 22
breast cancer (21) 21
index medicus (21) 21
female (20) 20
breast neoplasms - drug therapy (19) 19
chemotherapy (17) 17
middle aged (17) 17
adult (15) 15
cancer (13) 13
aged (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
breast neoplasms - pathology (9) 9
care and treatment (8) 8
clinical trials (8) 8
therapy (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
treatment outcome (7) 7
neoplasm metastasis (6) 6
research (6) 6
womens health (6) 6
aged, 80 and over (5) 5
analysis (5) 5
cyclophosphamide (5) 5
fertility preservation (5) 5
hematology, oncology and palliative medicine (5) 5
oncology, experimental (5) 5
abridged index medicus (4) 4
adjuvant treatment (4) 4
anthracyclines (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic agents, hormonal - therapeutic use (4) 4
breast neoplasms - surgery (4) 4
cancer therapies (4) 4
doxorubicin (4) 4
drug therapy (4) 4
efficacy (4) 4
fertility (4) 4
outcomes (4) 4
paclitaxel - administration & dosage (4) 4
pregnancy (4) 4
studies (4) 4
tumors (4) 4
women (4) 4
young-women (4) 4
adjuvant chemotherapy (3) 3
advanced breast cancer (3) 3
amenorrhea (3) 3
anthracycline (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
breast neoplasms - mortality (3) 3
consensus (3) 3
disease-free survival (3) 3
epirubicin (3) 3
epirubicin - administration & dosage (3) 3
fluorouracil - administration & dosage (3) 3
italy (3) 3
kaplan-meier estimate (3) 3
medicine & public health (3) 3
neoplasm grading (3) 3
neoplasm staging (3) 3
patients (3) 3
postmenopausal women (3) 3
premenopausal patients (3) 3
primary ovarian insufficiency - chemically induced (3) 3
receptor, erbb-2 - metabolism (3) 3
risk factors (3) 3
safety (3) 3
trastuzumab (3) 3
young adult (3) 3
adolescent (2) 2
age (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal, humanized (2) 2
antineoplastic agents - administration & dosage (2) 2
aromatase inhibitors (2) 2
aromatase inhibitors - therapeutic use (2) 2
breast (2) 2
breast neoplasms - complications (2) 2
breast neoplasms - diagnosis (2) 2
breast neoplasms - metabolism (2) 2
breast neoplasms - physiopathology (2) 2
cancer patients (2) 2
capecitabine (2) 2
cardiotoxicity (2) 2
chemotherapy, adjuvant (2) 2
chemotherapy, adjuvant - adverse effects (2) 2
cohort studies (2) 2
cyclophosphamide - administration & dosage (2) 2
cyclophosphamide - adverse effects (2) 2
cyclophosphamide - therapeutic use (2) 2
docetaxel (2) 2
dose-dense chemotherapy (2) 2
drug administration schedule (2) 2
drug dosages (2) 2
early breast-cancer (2) 2
epirubicin - adverse effects (2) 2
epirubicin - therapeutic use (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by De Placido, Sabino and Gallo, Ciro and De Laurentiis, Michelino and Bisagni, Giancarlo and Arpino, Grazia and Sarobba, Maria Giuseppa and Riccardi, Ferdinando and Russo, Antonio and Del Mastro, Lucia and Cogoni, Alessio Aligi and Cognetti, Francesco and Gori, Stefania and Foglietta, Jennifer and Frassoldati, Antonio and Amoroso, Domenico and Laudadio, Lucio and Moscetti, Luca and Montemurro, Filippo and Verusio, Claudio and Bernardo, Antonio and Lorusso, Vito and Gravina, Adriano and Moretti, Anna and Moretti, Gabriella and Lauria, Rossella and Lai, Antonella and Mocerino, Carmela and Rizzo, Sergio and Nuzzo, Antonio and Nuzzo, Francesco and Carlini, Paolo and Perrone, Francesco and Accurso, Antonello and Agostara, Biagio and Aieta, Michele and Alabiso, Oscar and Alicicco, Maria Grazia and Amadori, Dino and Amaducci, Laura and Amiconi, Gianna and Antuzzi, Giustino and Ardine, Mara and Ardizzoia, Antonio and Aversa, Caterina and Badalamenti, Giuseppe and Barni, Sandro and Basurto, Carlo and Berardi, Rossana and Bergamasco, Cinzia and Bidoli, Paolo and Bighin, Claudia and Biondi, Edoardo and Boni, Corrado and Borgonovo, Karen and Botta, Mario and Bravi, Stefano and Bruzzi, Paolo and Buono, Giuseppe and Butera, Alfredo and Caldara, Alessia and Candeloro, Giampiero and Cappelletti, Claudia and Cardalesi, Cinzia and Carfora, Elisabetta and Cariello, Anna and Carrozza, Francesco and Cartenì, Giacomo and Caruso, Michele and Casadei, Virginia and Casanova, Claudia and Castori, Luigi and Cavanna, Luigi and Cavazzini, Giovanna and Cazzaniga, Marina and Chilelli, Mario and Chiodini, Paolo and Chiorrini, Silvia and Ciardiello, Fortunato and Ciccarese, Mariangela and Cinieri, Saverio and Clerico, Mario and Coccaro, Mariarosa and Comande, Mario and Corbo, Claudia and Cortino, Giuseppina and Cusenza, Stefania and Daniele, Gennaro and D'arco, Alfonso Maria and D'auria, Giuliana and Dazzi, Claudio and De Angelis, Carmine and de Braud, Filippo and De Feo, Gianfranco and De Matteis, Andrea and De Tursi, Michele and Di Blasio, Anna and di Lucca, Giuseppe and Di Lullo, Liberato and Di Rella, Francesca and Di Renzo, Gianfranco and ... and GIM Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 474 - 485
Uncertainty exists about the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors and, to our knowledge, no trial has directly... 
SYSTEM | THERAPY | EFFICACY | ONCOLOGY | FOLLOW-UP | POSTMENOPAUSAL WOMEN | COMBINATION | AROMATASE INHIBITORS | Breast cancer | Product development | Tamoxifen | Analysis
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1863 - 1872
Journal Article
JAMA, ISSN 0098-7484, 07/2011, Volume 306, Issue 3, pp. 269 - 276
Journal Article
JAMA, ISSN 0098-7484, 12/2015, Volume 314, Issue 24, pp. 2632 - 2640
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2013, Volume 40, Issue 5, pp. 675 - 683
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 3/2016, Volume 24, Issue 3, pp. 1285 - 1294
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2016, Volume 160, Issue 2, pp. 261 - 267
Journal Article
Journal Article
Future Oncology, ISSN 1479-6694, 07/2013, Volume 9, Issue 7, pp. 955 - 957
Hurvitz SA, Dirix L, Kocsis J et al. Phase II randomised study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal... 
HER-2-positive metastatic breast cancer | trastuzumab emtansine | PLUS DOCETAXEL | ONCOLOGY
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 1/2016, Volume 155, Issue 1, pp. 117 - 126
Journal Article